|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||2.47 / 5.80|
He is also loading up on some biopharmaceutical stocks.
Investor's holdings have fallen along with the sector, but he's raising the stakes.
A truly contrarian investment strategy.
iBillionaire can serve as another quality stock screening tool.
Despite the recent volatility in the company's stock, TG Therapeutics cancer drugs are on track for approval and will ultimately fill a niche where old generic chemotherapies have failed.
Stocks flip-flop around the Herbalife and J.C. Penney dramas, while Keryx shines for bulls. TheStreet's Debra Borchardt has details.